A Phase Ic/IIb Study to Evaluate the Efficacy，Safety and Pharmacokinetics of HST in Patients With CHB
Clinical trial NCT06122454 · UNKNOWN
Trial details
- NCT number
- NCT06122454
- Sponsor
- Xi'an Xintong Pharmaceutical Research Co.,Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-10
- Primary completion
- 2024-06-06
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.